Evaxion A (EVAX) Non-Current Debt (2021 - 2025)

Evaxion A (EVAX) reported Non-Current Debt of $5.3 million for Q4 2025, down 33.23% on a YoY basis from $8.0 million in Q4 2024, and down 40.79% quarter-over-quarter from $9.0 million in Q2 2025.

Evaxion A (EVAX) Non-Current Debt (2021 - 2025) Analysis & Trends

Evaxion A has reported Non-Current Debt for 5 years, with the latest figure at $5.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Debt fell 33.23% year-over-year to $5.3 million; the trailing twelve-month figure through Dec 2025 stood at $5.3 million (down 33.23% YoY), and the FY2025 full-year result was $5.3 million, down 33.23% from the prior year.
  • Non-Current Debt for Q4 2025 stood at $5.3 million, down from $9.0 million in the prior quarter.
  • The five-year high for Non-Current Debt was $9.0 million in Q2 2025, with the low at $1.0 million in Q4 2021.
  • Historically, Non-Current Debt has averaged $6.6 million across 5 years, with a median of $7.9 million in 2022.
  • Annual changes were most pronounced in 2022 — Non-Current Debt surged 653.26% — and 2025, when it slumped 33.23%.
  • Evaxion A's Non-Current Debt stood at $1.0 million in 2021, then surged by 653.26% to $7.9 million in 2022, then advanced by 7.95% to $8.5 million in 2023, then decreased by 5.67% to $8.0 million in 2024, then tumbled by 33.23% to $5.3 million in 2025.
  • The last three Non-Current Debt figures came in at $5.3 million (Q4 2025), $9.0 million (Q2 2025), and $8.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 319.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Regeneron Pharmaceuticals 63.43 Bn 54.67 Bn 3.31 Bn 1.99 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 5.35 Mn
Dec 31, 2025 5.35 Mn
Jun 30, 2025 9.03 Mn
Jun 30, 2025 9.03 Mn
Dec 31, 2024 8.01 Mn
Dec 31, 2024 8.01 Mn
Jun 30, 2024 8.26 Mn
Jun 30, 2024 8.26 Mn
Dec 31, 2023 8.49 Mn
Dec 31, 2023 8.49 Mn
Jun 30, 2023 8.08 Mn
Jun 30, 2023 8.08 Mn
Dec 31, 2022 7.86 Mn
Dec 31, 2022 7.86 Mn
Jun 30, 2022 7.34 Mn
Jun 30, 2022 7.34 Mn
Mar 31, 2022 7.72 Mn
Mar 31, 2022 7.72 Mn
Dec 31, 2021 1.04 Mn
Dec 31, 2021 1.04 Mn